InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Scopelianos Angelo, Directeur de la R&D. Director active across 1 company, notably Axogen, Inc.. Cumulatively, 9 filings have been published. Activity tracked since 19 July 2021. The latest transaction was filed on 16 March 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Scopelianos Angelo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
21,281 股0Common StockSEC:0000805928-24-000047:0
2,571 股0Common StockSEC:0000805928-23-000138:0
8,250 股0Common StockSEC:0000805928-23-000024:0
1,150 股0Common StockSEC:0000805928-22-000137:0
2,571 股0Common StockSEC:0000805928-22-000094:0
11,000 股0Common StockSEC:0000805928-22-000034:0
1,325 股0Common StockSEC:0000805928-22-000013:0
1,150 股0Common StockSEC:0000805928-21-000184:0
2,572 股0Common StockSEC:0000805928-21-000144:0
9 条申报中的 9 条
About Scopelianos Angelo
Scopelianos Angelo is Directeur de la R&D and Chief R&D Officer at Axogen, Inc. The record shows 9 filings in total, and the 9 sampled filings cover the period from 2021-07-21 to 2024-03-25, with the transaction nature indicated as Levée d'options; the buy and sell amounts are 0.
